3628 results for «53»

Filter By

3628 results

Challenging vascular access and closure management

21 May 2025 – From EuroPCR 2025

Address challenging vascular access and closure management in complex TAVI cases. This session covers the selection of femoral access, use of PTA and intravascular lithotripsy, and strategies to manage closure failure with illustrative real-world cases.

Challenging vascular access and closure management

Calcified nodules: a different beast?

21 May 2025 – From EuroPCR 2025

This session offers a comprehensive exploration of calcified nodules, a challenging entity in PCI. Learn to identify these nodules with IVUS and OCT, understand their unique treatment challenges, and select optimal plaque modification tools through detailed case discussions.

Calcified nodules: a different beast?

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

21 May 2025 – From EuroPCR 2025

Reflect on the impact of recent trials REC-CAGEFREE 1 and PREVENT on the use of drug-coated balloons (DCB) and preventive PCI for vulnerable plaque. This session includes case discussions highlighting DCB applications and insights from cutting-edge clinical studies.

DCB after REC-CAGEFREE 1 - Vulnerable plaque PCI after PREVENT

Streamlining the TAVI pathway

21 May 2025 – From EuroPCR 2025

Optimize your TAVI pathway through this session focusing on streamlined pre-procedural planning, minimalist procedural techniques, and post-procedural discharge strategies. Learn how to safely deliver multiple cases per list and implement next-day or same-day discharge programs effectively.

Streamlining the TAVI pathway

ACS with normal coronary arteries: angiography done, job done?

21 May 2025 – From EuroPCR 2025

Understand the clinical significance of MINOCA and learn diagnostic strategies integrating invasive and non-invasive tests to identify underlying etiologies. This session provides therapeutic insights tailored to specific MINOCA endotypes through illustrative cases.

ACS with normal coronary arteries: angiography done, job done?

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

21 May 2025 – From EuroPCR 2025

Learn how to select appropriate cardiovascular interventions for tricuspid regurgitation patients by considering comorbidities, anatomical factors influencing procedural success, and imaging criteria for device selection. The session includes patient vignettes to illustrate decision-making pathways.

How to select appropriate cardiovascular intervention for a patient with tricuspid regurgitation?

Clinical outcomes of left main PCI

21 May 2025 – From EuroPCR 2025

This session reviews clinical outcomes of left main PCI in various contexts including ACS, complex lesion risk stratification with BCIS-CHIP score, and spontaneous coronary artery dissection. It also compares double-stent techniques and examines five-year results to guide clinical decision-making.

Clinical outcomes of left main PCI

A journey into the ANOCA and INOCA dilemma

21 May 2025 – From EuroPCR 2025

Explore the complex clinical dilemma of ANOCA and INOCA with focus on angina endotypes, prognostic stratification, metabolic phenotype associations, and microvascular function assessment using indices such as microcirculatory resistance and microvascular resistance reserve.

A journey into the ANOCA and INOCA dilemma

New devices for structural interventions

21 May 2025 – From EuroPCR 2025

Discover emerging devices transforming structural heart interventions. This session highlights biomimetic valve designs, new transcatheter aortic valve systems, novel devices for aortic insufficiency, leaflet resection, left atrial appendage closure, and short self-expanding TAVR valves with promising early results.

New devices for structural interventions

PCR's Got Talent - Round 2 - Session 2

21 May 2025 – From EuroPCR 2025

Experience a dynamic showcase of emerging talents and innovative cases in interventional cardiology during PCR's Got Talent Round 2 Session 2. This session highlights cutting-edge techniques and clinical insights from rising experts in the field.

PCR's Got Talent - Round 2 - Session 2

How should I treat this vulnerable plaque?

21 May 2025 – From EuroPCR 2025

Learn to identify and manage vulnerable plaque using intracoronary imaging. This session covers detection techniques, clinical implications, current evidence for treatment, and case-based insights to improve patient outcomes through targeted intervention.

How should I treat this vulnerable plaque?

Academic Research Consortium on LAA closure

21 May 2025 – From EuroPCR 2025

Gain comprehensive understanding of the Academic Research Consortium's achievements in left atrial appendage (LAA) closure. Learn how standardized endpoints are streamlined for randomized controlled trials and how collaborative efforts homogenize definitions to advance clinical research.

Academic Research Consortium on LAA closure

Major Late-Breaking Trials from EuroPCR 2025

21 May 2025 – From EuroPCR 2025

Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with...

Major Late-Breaking Trials from EuroPCR 2025

Treatment dilemmas in STEMI patients with multivessel disease

21 May 2025 – From EuroPCR 2025

Address treatment dilemmas in STEMI patients with multivessel disease through this session focused on imaging and physiology-guided revascularisation strategies. Learn optimal approaches for cases with CABG indications, and timing considerations for non-culprit vessel revascularisation during hospital admission or later stages, supported by illustrative clinical cases.

Treatment dilemmas in STEMI patients with multivessel disease

Management of high-risk left main lesion

21 May 2025 – From EuroPCR 2025

Focus on managing high-risk left main coronary lesions with this session featuring complex cases such as thrombotic lesions, calcified distal left main PCI with orbital atherectomy and IVUS guidance, and advanced stenting techniques. Learn practical approaches for challenging anatomical and clinical scenarios to optimize patient outcomes.

Management of high-risk left main lesion

Did danger shock change my practice?

21 May 2025 – From EuroPCR 2025

Reflect on how contemporary management of cardiogenic shock has evolved through this session. Review collaborative strategies, challenging clinical cases involving STEMI, multivessel disease, refractory shock, spontaneous coronary artery dissection, and the critical role of intracoronary imaging in guiding interventional decisions.

Did danger shock change my practice?

Stent technologies, last evidence in coronary interventions

21 May 2025 – From EuroPCR 2025

Update your knowledge on the latest stent technologies and clinical evidence in coronary interventions. This session reviews long-term outcomes of resorbable magnesium scaffolds, seven-year data from the COMPARE-ABSORB trial, bioadaptor versus stent comparisons, dual therapy sirolimus-eluting versus biolimus-eluting stents, and randomized trials on direct stenting versus...

Stent technologies, last evidence in coronary interventions

Strategies in treating double CTO scenarios

21 May 2025 – From EuroPCR 2025

Navigate complex double chronic total occlusion (CTO) scenarios with this session that emphasizes thorough lesion qualification and innovative techniques. Learn strategies including management of ambiguous proximal caps, sequential vessel revascularization, and advanced tools like snaring and deflection to optimize procedural success.

Strategies in treating double CTO scenarios

Case-based learning on different aspects of transcatheter LAA closure

21 May 2025 – From EuroPCR 2025

Engage in case-based learning focused on transcatheter left atrial appendage (LAA) closure. This session covers safe transseptal puncture techniques, state-of-the-art standard LAA closure procedures, management of challenging LAA anatomies, and optimization of post-procedure antithrombotic therapy in high-risk patients.

Case-based learning on different aspects of transcatheter LAA closure

TAVI for aortic regurgitation: off-label use

21 May 2025 – From EuroPCR 2025

Explore the complexities and off-label challenges of transcatheter aortic valve implantation (TAVI) in patients with severe pure aortic regurgitation. This session highlights the bold strategies, complication management, and innovative use of the Octacor valve in this demanding clinical scenario, providing valuable insights into navigating a difficult...

TAVI for aortic regurgitation: off-label use
Didn’t find what you were looking for?